(CIDRAP News) A group of influenza experts convened by the World Health Organization cautioned today that governments shouldn't stockpile "pre-pandemic" H5N1 influenza vaccines now, because too little is known about the requirements for an effective vaccine.
(CIDRAP News) – Low doses of a cell-based avian flu vaccine triggered a good immune response to the H5N1 avian influenza virus, according to preliminary results of a clinical trial by Baxter International of Deerfield, Ill., maker of the vaccine.
(CIDRAP News) The human immune system may respond better to a vaccine for a new strain of H5N1 avian influenza if it is prepared in advance with a vaccine based on an existing H5N1 strain, the preliminary results of a government-sponsored study suggest.
(CIDRAP News) Recent tests suggest that an antiviral drug given by intravenous (IV) or intramuscular (IM) injection could eventually serve as another weapon against influenza, according to results presented at a conference last week.
(CIDRAP News) Indonesia reported its 69th H5N1 avian influenza case today, in the 21-year-old sister of an 11-year-old boy who died of the same disease on Sep 18.
The woman from the Tulungagung district of East Java tested positive for H5N1 today, 4 days after she was hospitalized, according to a Bloomberg News report. The World Health Organization (WHO) confirmed her 11-year-old brother's case on Sep 25.
(CIDRAP News) A study in which mice were infected with the resurrected 1918 Spanish influenza virus has yielded fresh evidence for the view that the virus could trigger a suicidal immune responseone that has often been compared with the effects of the H5N1 avian flu virus on susceptible humans.